The latest price target for QuidelOrtho (NASDAQ:QDEL) was reported by UBS on September 19, 2024. The analyst firm set a price target for $50.00 expecting QDEL to rise to within 12 months (a possible 8.15% upside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for QuidelOrtho (NASDAQ:QDEL) was provided by UBS, and QuidelOrtho upgraded their neutral rating.

The last upgrade for QuidelOrtho Corp happened on September 19, 2024 when UBS raised their price target to $50. UBS previously had a sell for QuidelOrtho Corp.

The last downgrade for QuidelOrtho Corp happened on March 4, 2024 when UBS changed their price target from $70 to $42 for QuidelOrtho Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of QuidelOrtho, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for QuidelOrtho was filed on September 19, 2024 so you should expect the next rating to be made available sometime around September 19, 2025.

While ratings are subjective and will change, the latest QuidelOrtho (QDEL) rating was a upgraded with a price target of $42.00 to $50.00. The current price QuidelOrtho (QDEL) is trading at is $46.23, which is within the analyst’s predicted range.